Approximately 75% of U.S. patients face challenges in taking prescribed medicines due to factors like high costs, copayments, complex treatment regimens, and poor health literacy. The program, leveraging Sempre’s technology, provides discounts at the point-of-sale, increasing as patients adhere to their medication regimens.

Organon and Sempre Health have announced a strategic partnership aimed at promoting medication adherence and timely prescription refills. The innovative pricing program, applicable to medications such as Dulera and Asmanex, offers eligible patients discounts throughout their therapy to encourage adherence. Eligible patients receive discounts at the point-of-sale, which increase as they remain on therapy and continue to fill on-time, helping them fill their medications and save money. The program also includes natural language text message engagement, which leads to a personalized experience for those enrolled.

This initiative addresses a significant clinical and economic issue in the United States, where non-adherence costs between $100 billion to $300 billion annually. The partnership aims to empower patients to take control of their health, improve adherence, and save money simultaneously, with positive feedback from enrolled patients already highlighting its impact.

Article written by Organon